Related Experiment Video
Updated: Jun 27, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
Ciprofloxacin strongly inhibits clozapine metabolism: two case reports
E E M Brouwers1, M Söhne, S Kuipers
1Department of Pharmacy and Pharmacology, Slotervaart Hospital, the Netherlands Cancer Institute, Amsterdam, the Netherlands. Elke.Brouwers@slz.nl
Abstract:
We report on two cases of drug-drug interactions between ciprofloxacin and clozapine. The first case was a 46-year-old male patient receiving a daily dose of clozapine 900 mg. He was admitted to hospital with urosepsis and was treated with a 5-day course of ciprofloxacin and amoxicillin. Two days after completion of antibacterial therapy, the patient developed symptoms of rhabdomyolysis. Clozapine therapy was discontinued and measurement of the patient's clozapine plasma concentration 1 day after cessation of clozapine therapy and 3 days after cessation of ciprofloxacin treatment showed that it was in excess of recommended therapeutic levels. The second patient was a 58-year-old male patient treated with a daily dose of clozapine 300 mg. He was admitted to hospital because of delirium and suspected urinary tract infection or pneumonia. Treatment with ciprofloxacin was initiated. Measurement of clozapine plasma concentrations prior to and 3 days after commencement of ciprofloxacin showed that clozapine concentrations doubled over that time period. We suggest that inhibition of cytochrome P450 (CYP) enzymes 1A2 and 3A4 by ciprofloxacin resulted in delayed clozapine metabolism and elevated clozapine plasma concentrations. This might cause severe adverse effects. We advise using another antibacterial agent or reducing the clozapine dose and monitoring clozapine levels when this antipsychotic agent is used in combination with ciprofloxacin.
Insights
Ciprofloxacin can dangerously increase clozapine levels, potentially causing severe side effects. Monitor clozapine concentrations closely or use alternative antibiotics when these drugs are combined.
Area of Science:
- Pharmacology
- Clinical Toxicology
Background:
- Clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia.
- Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic.
Observation:
- Two patients experienced elevated clozapine plasma concentrations after receiving ciprofloxacin.
- One patient developed rhabdomyolysis, a severe adverse effect, concurrent with high clozapine levels.
Findings:
- Ciprofloxacin likely inhibits CYP1A2 and CYP3A4 enzymes, impairing clozapine metabolism.
- This drug-drug interaction can lead to significantly increased clozapine levels and potential toxicity.
Implications:
- Clinicians should exercise caution when co-prescribing ciprofloxacin and clozapine.
- Monitoring clozapine levels or considering alternative antibiotics is recommended to prevent adverse events.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Psychosis: Goals of Pharmacotherapy
Pharmacokinetics: Drug–Drug Interactions
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Antipsychotic Drugs: Typical and Atypical Agents
